Prognostic factors and effect modifiers for personalisation of internet-based cognitive behavioural therapy among university students with subthreshold depression: A secondary analysis of a factorial trial.

[1]  A. Tajika,et al.  Validation of the Japanese Big Five Scale Short Form in a University Student Sample , 2022, Frontiers in Psychology.

[2]  S. Hollon,et al.  Components of smartphone cognitive-behavioural therapy for subthreshold depression among 1093 university students: a factorial trial , 2022, Evidence-Based Mental Health.

[3]  R. Kessler,et al.  Time for united action on depression: a Lancet–World Psychiatric Association Commission , 2022, The Lancet.

[4]  Andrea K. Graham,et al.  The effect of depression and anxiety symptom severity on clinical outcomes and app use in digital mental health treatments: Meta-regression of three trials. , 2021, Behaviour research and therapy.

[5]  P. Cuijpers,et al.  Psychotherapies for depression: a network meta‐analysis covering efficacy, acceptability and long‐term outcomes of all main treatment types , 2021, World psychiatry : official journal of the World Psychiatric Association.

[6]  Alishia D. Williams,et al.  Dismantling, optimising, and personalising internet cognitive behavioural therapy for depression: a systematic review and component network meta-analysis using individual participant data. , 2021, The lancet. Psychiatry.

[7]  Alishia D. Williams,et al.  Internet-Based Cognitive Behavioral Therapy for Depression: A Systematic Review and Individual Patient Data Network Meta-analysis. , 2021, JAMA psychiatry.

[8]  T. Furukawa,et al.  Development and validation of the Cognitive Behavioural Therapy Skills Scale among college students , 2021, Evidence-Based Mental Health.

[9]  M. Rose,et al.  Do sociodemographic variables moderate effects of an internet intervention for mild to moderate depressive symptoms? An exploratory analysis of a randomised controlled trial (EVIDENT) including 1013 participants , 2021, BMJ Open.

[10]  Blanca S Pineda,et al.  Psychological interventions to prevent the onset of depressive disorders: A meta-analysis of randomized controlled trials. , 2020, Clinical psychology review.

[11]  D. Kounali,et al.  How much change is enough? Evidence from a longitudinal study on depression in UK primary care , 2020, Psychological Medicine.

[12]  Dan J Stein,et al.  The clinical characterization of the adult patient with depression aimed at personalization of management , 2020, World psychiatry : official journal of the World Psychiatric Association.

[13]  S. Hofmann.  The Age of Depression and Its Treatments. , 2020, JAMA psychiatry.

[14]  N. Kawakami,et al.  Construct validity and test-retest reliability of the World Mental Health Japan version of the World Health Organization Health and Work Performance Questionnaire Short Version: a preliminary study , 2020, Industrial health.

[15]  T. Peters,et al.  Comparison between self-administered depression questionnaires and patients' own views of changes in their mood: a prospective cohort study in primary care , 2020, Psychological Medicine.

[16]  Herman Aguinis,et al.  On reporting and interpreting statistical significance and p values in medical research , 2019, BMJ Evidence-Based Medicine.

[17]  S. Yamawaki,et al.  Exploratory analyses of effect modifiers in the antidepressant treatment of major depression: Individual-participant data meta-analysis of 2803 participants in seven placebo-controlled randomized trials. , 2019, Journal of affective disorders.

[18]  M. Horikoshi,et al.  Factorial Validity and Invariance of the 7-Item Generalized Anxiety Disorder Scale (GAD-7) Among Populations With and Without Self-Reported Psychiatric Diagnostic Status , 2018, Front. Psychol..

[19]  J. Wason,et al.  Healthy Campus Trial: a multiphase optimization strategy (MOST) fully factorial trial to optimize the smartphone cognitive behavioral therapy (CBT) app for mental health promotion among university students: study protocol for a randomized controlled trial , 2018, Trials.

[20]  P. Cuijpers,et al.  Cognitive-Behavioral Analysis System of Psychotherapy, Drug, or Their Combination for Persistent Depressive Disorder: Personalizing the Treatment Choice Using Individual Participant Data Network Metaregression , 2018, Psychotherapy and Psychosomatics.

[21]  E. Shimizu,et al.  Performance of the Japanese version of the Patient Health Questionnaire-9 (J-PHQ-9) for depression in primary care. , 2018, General hospital psychiatry.

[22]  Glyn Lewis,et al.  Why are there discrepancies between depressed patients’ Global Rating of Change and scores on the Patient Health Questionnaire depression module? A qualitative study of primary care in England , 2017, BMJ Open.

[23]  Naoya Todo,et al.  Psychometric Properties of the Japanese CES–D, SDS, and PHQ–9 Depression Scales in University Students , 2017, Psychological assessment.

[24]  V. Patel,et al.  The impact of digital technology on psychological treatments and their dissemination , 2017, Behaviour research and therapy.

[25]  R. Kessler,et al.  Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder , 2016, Epidemiology and Psychiatric Sciences.

[26]  K Bennett,et al.  Predictors and moderators of response to internet-delivered Interpersonal Psychotherapy and Cognitive Behavior Therapy for depression. , 2013, Journal of affective disorders.

[27]  Iori Tani,et al.  [Development of a short form of the Japanese big-five scale, and a test of its reliability and validity]. , 2012, Shinrigaku kenkyu : The Japanese journal of psychology.

[28]  B. Löwe,et al.  The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. , 2010, General hospital psychiatry.

[29]  Anthony F Jorm,et al.  Beliefs of Young People and Their Parents about the Effectiveness of Interventions for Mental Disorders , 2007, The Australian and New Zealand journal of psychiatry.

[30]  B. Löwe,et al.  A brief measure for assessing generalized anxiety disorder: the GAD-7. , 2006, Archives of internal medicine.

[31]  Tomonori Koyama,et al.  Autism‐Spectrum Quotient–Japanese version and its short forms for screening normally intelligent persons with pervasive developmental disorders , 2005, Psychiatry and clinical neurosciences.

[32]  Ronald C. Kessler,et al.  The World Health Organization Health and Work Performance Questionnaire (HPQ) , 2003, Journal of occupational and environmental medicine.

[33]  R. Spitzer,et al.  The PHQ-9 , 2001, Journal of General Internal Medicine.

[34]  S. Baron-Cohen,et al.  The Autism-Spectrum Quotient (AQ): Evidence from Asperger Syndrome/High-Functioning Autism, Malesand Females, Scientists and Mathematicians , 2001, Journal of autism and developmental disorders.

[35]  T. Furukawa,et al.  Social Support Questionnaire among psychiatric patients with various diagnoses and normal controls , 1999, Social Psychiatry and Psychiatric Epidemiology.

[36]  S. Wada.  Construction of the Big Five Scales of personality trait terms and concurrent validity with NPI. , 1996 .

[37]  Irwin G. Sarason,et al.  A Brief Measure of Social Support: Practical and Theoretical Implications , 1987 .

[38]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .